Lite Strategy, Inc. Cash and Restricted Cash
Lite Strategy, Inc. (LITS) had Cash and Restricted Cash of $12.55 million as of 2021-12-31, per its 10-Q/A filed 2022-05-23.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2022-05-23
- 2021-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12.55M.
- 2021-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15.62M.
- 2021-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.54M.
- 2020-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $9.88M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2021-12-31 | $12.55M 10-Q/A · filed 2022-05-23 |
| 2021-09-30 | $15.62M 10-Q/A · filed 2022-05-23 |
| 2021-06-30 | $8.54M 10-K/A · filed 2022-05-23 |
| 2020-12-31 | $9.88M 10-Q/A · filed 2022-05-23 |
| 2020-09-30 | $10.96M 10-Q/A · filed 2022-05-23 |
| 2020-06-30 | $12.33M 10-K/A · filed 2022-05-23 |
| 2019-06-30 | $9.59M 10-K/A · filed 2022-05-23 |
| 2018-06-30 | $13.31M 10-K/A · filed 2022-05-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |